41 results
Page 2 of 3
8-K
EX-99.1
id2 7ryof1lie7e9nfc
3 Nov 14
Other Events
12:00am
8-K
EX-99.3
n8r1bfiltfdqwyl
6 Oct 14
Departure of Directors or Certain Officers
12:00am
8-K
EX-99.1
63w8kou tvx
17 Sep 14
Regulation FD Disclosure
12:00am
8-K
EX-99.1
ti5ac3 l6zzyj5kx
23 Dec 13
BioTime’s Subsidiary Cell Cure Neurosciences Ltd. Awarded $1.7 Million Grant From Israel’s Office of the Chief Scientist
12:00am
8-K
EX-99.1
zdb4av2 xrl1g
1 Aug 12
BioTime’s Subsidiary Cell Cure Neurosciences Ltd. Awarded $1.33 Million Grant From Israel’s Office of the Chief Scientist
12:00am
8-K
EX-99.2
r428mmrqjiix2 v8l3
23 Apr 12
BioTime Provides Update on ReneviaTM Product Development
12:00am
8-K
EX-99.2
i507wlnh
12 Oct 10
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
3ga2h0 p3mcyx9ak83x
12 Oct 10
Entry into a Material Definitive Agreement
12:00am
DEFA14A
mr8e757w6jx7vxfa9
14 May 10
Additional proxy soliciting materials
12:00am
8-K
EX-99.1
wqvegd9
10 Mar 10
Biotime Announces Fourth Quarter and Fiscal Year-end 2009
12:00am
S-2
EX-1
v0dsvukoeyi
2 Sep 05
Registration of securities
12:00am
POS AM
EX-10.20
mmwwujvedsvfu5x
24 May 05
Prospectus update (post-effective amendment)
12:00am
S-2
EX-10.19
6g88q 74ue
3 Oct 03
Registration of securities
12:00am